In September, Stryker announced plans to acquire the company for $190 million, or $7.40 per share. The acquisition is expected to have an immaterial impact on Stryker’s net earnings in 2018.
Invuity develops photonics and single-use, lighted instruments to enhance visualization for a wide variety of clinical applications, including orthopedic and spine surgery.
More articles on devices and implants:
Intuitive Surgical records $921M in Q3 revenue: 3 things to know
Stryker extends $1.4B K2M acquisition deadline: 5 key points
Global spine surgery devices market to reach $2.98B by 2022 –– 9 key companies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
